Endovascular Thrombectomy Outcomes with and without Intravenous Thrombolysis for Large Ischemic Cores Identified with CT or MRI

被引:10
作者
Derraz, Imad [1 ]
Moulin, Solene [3 ]
Gory, Benjamin [4 ]
Kyheng, Maeva [5 ]
Arquizan, Caroline [2 ]
Costalat, Vincent [1 ]
Lapergue, Bertrand [6 ]
机构
[1] Montpellier Univ, Med Ctr, Hop Gui de Chauliac, Dept Neuroradiol, 80 Ave Augustin Fliche, F-34295 Montpellier, France
[2] Montpellier Univ, Hop Gui de Chauliac, Dept Neurol, Med Ctr, 80 Ave Augustin Fl, F-34295 Montpellier, France
[3] Reims Univ Hosp Ctr, Dept Neurol, Reims, France
[4] Nancy Univ Hosp Ctr, Dept Neuroradiol, Nancy, France
[5] Univ Lille, Dept Biostat, Lille Univ Hosp Ctr, EA Publ Hlth Epidemiol & Qual Care 2694, Lille, France
[6] Univ Versailles St Quentin En Yvelines, Foch Hosp, Dept Neurol, Suresnes, France
关键词
MECHANICAL THROMBECTOMY; BRIDGING THERAPY; STROKE; TISSUE; RECANALIZATION; ALTEPLASE;
D O I
10.1148/radiol.230440
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: Whether intravenous thrombolysis (IVT) prior to endovascular thrombectomy (EVT) provides additional benefits in patients with acute ischemic stroke (AIS) and a large infarct core (LIC) remains unclear.Purpose: To examine whether treatment with IVT before EVT is beneficial in patients with LIC identified with CT or MRI (Alberta Stroke Program Early CT score 0-5).Materials and Methods: This retrospective study included consecutive adult patients diagnosed with AIS due to large vessel occlusion (LVO) and LIC treated with EVT who were enrolled in the ETIS (Endovascular Treatment in Ischemic Stroke) Registry in France between January 2015 and January 2022. The primary outcome measure was a favorable outcome (modified Rankin Scale [mRS] score 0-3) at 90 days. Secondary outcomes included functional independence (mRS score 0-2) at 90 days, improvement in degree of disability (ordinal shift in mRS score toward a better outcome) at 90 days, early neurologic improvement at 24 hours, and successful reperfusion (modified Thrombolysis in Cerebral Infarction score of 2b or higher). Safety outcomes included symptomatic intracerebral hemorrhage within 24 hours and mortality at 90 days. Inverse probability of treatment weighting (IPTW)-adjusted analysis was used to assess the treatment effect of IVT adjusted for baseline variables.Results: Of 1408 patients (mean age, 68.3 years +/- 15.4 [SD]; 789 men), 654 (46.4%) were treated with IVT prior to EVT. In the IPTW-adjusted data set, IVT plus EVT was associated with a higher rate of favorable outcome at 90 days (odds ratio [OR], 1.24 [95% CI: 1.05, 1.46]; P = .01), functional independence at 90 days (OR, 1.47 [95% CI: 1.22, 1.77]; P < .001), improvement in degree of disability at 90 days (common OR, 1.30 [95% CI: 1.13, 1.49]; P < .001), early neurologic improvement (OR, 1.26 [95% CI: 1.07, 1.49]; P = .005), and successful reperfusion (OR, 1.43 [95% CI: 1.14, 1.79]; P = .002) than EVT alone. Rates of brain hemorrhage within 24 hours and mortality at 90 days were similar between groups.Conclusion: In patients with AIS due to LVO with LIC identified with CT or MRI, treatment with IVT before EVT appeared to provide a clinical benefit over EVT alone.
引用
收藏
页数:8
相关论文
共 35 条
[1]   A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality [J].
Austin, Peter C. .
MULTIVARIATE BEHAVIORAL RESEARCH, 2011, 46 (01) :119-151
[2]   Direct Mechanical Intervention Versus Bridging Therapy in Stroke Patients Eligible for Intravenous Thrombolysis A Pooled Analysis of 2 Registries [J].
Bellwald, Sebastian ;
Weber, Ralph ;
Dobrocky, Tomas ;
Nordmeyer, Hannes ;
Jung, Simon ;
Hadisurya, Jeffrie ;
Mordasini, Pasquale ;
Mono, Marie-Luise ;
Stracke, Christian P. ;
Sarikaya, Hakan ;
Bernasconi, Corrado ;
Berger, Klaus ;
Arnold, Marcel ;
Chapot, Rene ;
Gralla, Jan ;
Fischer, Urs .
STROKE, 2017, 48 (12) :3282-3288
[3]   Hemorrhagic transformation of ischemic brain tissue -: Asymptomatic or symptomatic? [J].
Berger, C ;
Fiorelli, M ;
Steiner, T ;
Schäbitz, WR ;
Bozzao, L ;
Bluhmki, E ;
Hacke, W ;
von Kummer, R .
STROKE, 2001, 32 (06) :1330-1335
[4]   Benefit of Intravenous Alteplase before Thrombectomy Depends on ASPECTS [J].
Broocks, Gabriel ;
Heit, Jeremy J. ;
Kuraitis, Gabriella M. ;
Meyer, Lukas ;
van Horn, Noel ;
Bechstein, Matthias ;
Thaler, Christian ;
Christensen, Soren ;
Mlynash, Michael ;
Lansberg, Maarten G. ;
Kemmling, Andre ;
Schon, Gerhard ;
Albers, Gregory ;
Fiehler, Jens ;
Wintermark, Max ;
Faizy, Tobias D. .
ANNALS OF NEUROLOGY, 2022, 92 (04) :588-595
[5]   Benefit and risk of intravenous alteplase in patients with acute large vessel occlusion stroke and low ASPECTS [J].
Broocks, Gabriel ;
McDonough, Rosalie ;
Bechstein, Matthias ;
Hanning, Uta ;
Brekenfeld, Caspar ;
Flottmann, Fabian ;
Kniep, Helge ;
Nawka, Marie Teresa ;
Deb-Chatterji, Milani ;
Thomalla, Goetz ;
Sporns, Peter ;
Yeo, Leonard L. L. ;
Tan, Benjamin Y. Q. ;
Gopinathan, Anil ;
Kastrup, Andreas ;
Politi, Maria ;
Papanagiotou, Panagiotis ;
Kemmling, Andre ;
Fiehler, Jens ;
Meyer, Lukas .
JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2023, 15 (01) :8-+
[6]   Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke [J].
Brown, DL ;
Johnston, KC ;
Wagner, DP ;
Haley, EC .
STROKE, 2004, 35 (01) :147-150
[7]   Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke [J].
Chalos, Vicky ;
LeCouffe, Natalie E. ;
Uyttenboogaart, Maarten ;
Lingsma, Hester F. ;
Mulder, Maxim J. H. L. ;
Venema, Esmee ;
Treurniet, Kilian M. ;
Eshghi, Omid ;
van der Worp, H. Bart ;
van der Lugt, Aad ;
Roos, Yvo B. W. E. M. ;
Majoie, Charles B. L. M. ;
Dippel, Diederik W. J. ;
Roozenbeek, Bob ;
Coutinho, Jonathan M. ;
van Oostenbrugge, Robert J. ;
van Zwam, Wim H. ;
Boiten, Jelis ;
Vos, Jan Albert ;
Jansen, Ivo G. H. ;
Goldhoorn, Robert-Jan B. ;
Schonewille, Wouter J. ;
Wermer, Marieke J. H. ;
van Walderveen, Marianne A. A. ;
Staals, Julie ;
Hofmeijer, Jeannette ;
Martens, Jasper M. ;
Nijeholt, Geert J. Lycklama A. ;
Emmer, Bart J. ;
de Bruijn, Sebastiaan F. ;
van Dijk, Lukas C. ;
Lo, Rob H. ;
van Dijk, Ewoud J. ;
Boogaarts, Hieronymus D. ;
de Kort, Paul L. M. ;
Peluso, Jo J. P. ;
van den Berg, Jan S. P. ;
van Hasselt, Boudewijn A. A. M. ;
Aerden, Leo A. M. ;
Dallinga, Rene J. ;
Schreuder, Tobien H. C. M. L. ;
Heijboer, Roel J. J. ;
Keizer, Koos ;
Yo, Lonneke S. F. ;
den Hertog, Heleen M. ;
Sturm, Emiel J. C. ;
Sprengers, Marieke E. S. ;
Jenniskens, Sjoerd F. M. ;
van den Berg, Rene ;
Yoo, Albert J. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (11)
[8]   The End of Tissue-Type Plasminogen Activator's Reign? [J].
Derraz, Imad .
STROKE, 2022, 53 (08) :2683-2694
[9]  
Donnelly J, 2023, Stroke Vasc Interv Neurol, V3
[10]   Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials [J].
Emberson, Jonathan ;
Lees, Kennedy R. ;
Lyden, Patrick ;
Blackwell, Lisa ;
Albers, Gregory ;
Bluhmki, Erich ;
Brott, Thomas ;
Cohen, Geoff ;
Davis, Stephen ;
Donnan, Geoffrey ;
Grotta, James ;
Howard, George ;
Kaste, Markku ;
Koga, Masatoshi ;
von Kummer, Ruediger ;
Lansberg, Maarten ;
Lindley, Richard I. ;
Murray, Gordon ;
Olivot, Jean Marc ;
Parsons, Mark ;
Tilley, Barbara ;
Toni, Danilo ;
Toyoda, Kazunori ;
Wahlgren, Nils ;
Wardlaw, Joanna ;
Whiteley, William ;
del Zoppo, Gregory J. ;
Baigent, Colin ;
Sandercock, Peter ;
Hacke, Werner .
LANCET, 2014, 384 (9958) :1929-1935